Kadela-Tomanek Monika, Jastrzębska Maria, Chrobak Elwira, Bębenek Ewa
Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.
Silesian Center for Education and Interdisciplinary Research, Institute of Physics, University of Silesia, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland.
Pharmaceutics. 2022 Dec 22;15(1):34. doi: 10.3390/pharmaceutics15010034.
Lipophilicity is one of the basic properties of a potential drug determining its solubility in non-polar solvents and, consequently, its ability to passively penetrate the cell membrane, as well as the occurrence of various pharmacokinetic processes, including adsorption, distribution, metabolism, excretion, and toxicity (ADMET). Heterocyclic compounds containing a nitrogen atom play a significant role in the search for new drugs. In this study, lipophilicity as well as other physicochemical, pharmacokinetic and toxicity properties affecting the bioavailability of the quinolone-1,4-quinone hybrids are presented. Lipophilicity was determined experimentally as well as theoretically using various computer programs. The tested compounds showed low values of experimental lipophilicity and its relationship with the type of 1,4-quinone moiety. Introduction of the nitrogen atom reduced the lipophilicity depending on the position at the 5,8-quinolinedione moiety. The bioavailability of the tested compounds was determined in silico using the ADMET parameters. The obtained parameters showed that most of the hybrids can be used orally and do not exhibit neurotoxic effects. Similarity analysis was used to examine the relationship between the ADMET parameters and experimental lipophilicity. The ability of hybrids to interact with biological targets was characterized by global reactivity descriptors. The molecular docking study showed that the hybrids can inhibit the BCL-2 protein.
亲脂性是潜在药物的基本性质之一,它决定了药物在非极性溶剂中的溶解度,进而决定其被动穿透细胞膜的能力,以及各种药代动力学过程的发生情况,包括吸收、分布、代谢、排泄和毒性(ADMET)。含氮杂环化合物在新药研发中起着重要作用。本研究介绍了影响喹诺酮 - 1,4 - 醌杂化物生物利用度的亲脂性以及其他物理化学、药代动力学和毒性性质。亲脂性通过实验以及使用各种计算机程序进行理论测定。测试的化合物显示出较低的实验亲脂性值及其与1,4 - 醌部分类型的关系。氮原子的引入根据其在5,8 - 喹啉二酮部分的位置降低了亲脂性。使用ADMET参数通过计算机模拟测定了测试化合物的生物利用度。获得的参数表明,大多数杂化物可口服使用且不表现出神经毒性作用。使用相似性分析来研究ADMET参数与实验亲脂性之间的关系。通过全局反应性描述符表征杂化物与生物靶点相互作用的能力。分子对接研究表明,这些杂化物可以抑制BCL - 2蛋白。